搜索筛选:
搜索耗时0.0953秒,为你在为你在102,285,761篇论文里面共找到 9 篇相符的论文内容
类      型:
[期刊论文] 作者:Yuefei Zhu,Jia Li,Zhiqing Pang, 来源:亚洲药物制剂科学(英文) 年份:2021
SARS-CoV-2 has been marked as a highly pathogenic coronavirus of COVID-19 disease into the human population,causing over 5.5 million confirmed cases worldwide.A...
[期刊论文] 作者:Huile Gao,Zhiqing Pang,Wei He, 来源:药学学报(英文版) 年份:2020
Drug delivery to treat cancer has attracted considerably and increasingly high attention.Several drug delivery systems are available in the market and many othe...
[会议论文] 作者:Bo Zhang,Zhiqing Pang,Yu Hu, 来源:第三届国际纳米药物大会 ChinaNanomedicine 2018 The 3rd International Con 年份:2018
  Nanomedicines including liposomes,micelles,and nanoparticles based on the enhanced permeability and retention(EPR)effect have become the mainstream for tumo...
[会议论文] 作者:Bo Zhang,Zhiqing Pang,Yu Hu, 来源:2013年中国药物制剂大会——中国药学会药剂专业委员会2013年学术年会暨国际控释协会中国分会2013年学术年会 年份:2013
The dual-targeting paclitaxel-loaded nanoparticles were developed by decoration with peptide-22, a novel peptide with special affinity to the low density lipoprotein receptor (LDLR), for transporting...
[会议论文] 作者:Bo Zhang,Yu Hu,Zhiqing Pang, 来源:2016年中国药物制剂大会、中国药学会药剂专业委员会2016年学术年会、中国化学制药工业协会固体制剂专业委员会2016年 年份:2016
Barriers presented by the tumor microenvironment including the abnormal tumor vasculature and interstitial matrix invariably lead to heterogeneous distribution of nanotherapeutics....
[期刊论文] 作者:Kai Jin,Zimiao Luo,Bo Zhang,Zhiqing Pang, 来源:药学学报(英文版) 年份:2018
There have been many recent exciting developments in biomimetic nanoparticles for biomedical applications.Inflammation,a protective response involving immune ce...
[期刊论文] 作者:Thamphiwatana,Ying Zheng,Zhiqing Pang, 来源:药学学报(英文版) 年份:2020
Cancer immunotherapy has veered the paradigm of cancer treatment.Despite recent ad-vances in immunotherapy for improved antitumor efficacy,the complicated tumor...
[会议论文] 作者:Zimiao Luo,Kai Jin,Qiang Pang,Zhiqiang Yan,Zhiqing Pang,Lei Yu, 来源:2016年中国药物制剂大会、中国药学会药剂专业委员会2016年学术年会、中国化学制药工业协会固体制剂专业委员会2016年 年份:2016
[期刊论文] 作者:Xinping Kuai,Yuefei Zhu,Zheng Yuan,Shengyu Wang,Lin Lin,Xiaodan Ye,Yiping Lu,Yu Luo,Zhiqing Pang,Daoying, 来源:药学学报(英文版) 年份:2022
Tumor-targeted immunotherapy is a remarkable breakthrough,offering the inimitable advan-tage of specific tumoricidal effects with reduced immune-associated cytotoxicity.However,existing plat-forms suffer from low efficacy,inability to induc......
相关搜索: